PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care

Presentations

• 02:30pm - 03:45pm PT

  10-year Experience of Ultra-Hypofractionated SBRT for Adrenal Metastases

  Speaker: Edward Chmiel, MD - Peter MacCallum Cancer Institute, East Melbourne
• 02:30pm - 03:45pm PT

  3-Dimensional Treatment Planning and Target Volume Definition of Osteoarthritis - Recommendations of the International Benign Target Volume Peer Group

  Speaker: David Rene Steike, MD - University Hospital of Muenster, Muenster
• 02:30pm - 03:45pm PT

  A Large Animal Study of a Novel Cardiac-Ultrasound Image Guidance for Cardio-Respiratory-Gated Radiation Ablation to Ventricular Tachycardia Targets Using Proton Therapy

  Speaker: Yen-Lin Evelyn Chen, MD - Massachusetts General Hospital, Boston
• 02:30pm - 03:45pm PT

  A Longitudinal CT-Based Subregional Radiomics Nomogram for Predicting Local Recurrence-Free Survival in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy: A Multicenter Study

  Speaker: Jie Gong, PhD - Department of Radiation Oncology, Xijing Hospital, Air Force Medical University. Xi’an, China, Xi'an
• 02:30pm - 03:45pm PT

  A Machine Learning Model Based on Computed Tomography Radiomics for the Prediction of the Response to SBRT in Lung Metastasis from Colorectal Cancer

  Speaker: Donatella Caivano, MD, PhD student - Sapienza University of Rome, Rome
• 02:30pm - 03:45pm PT

  A Multi-Dimensional Deep Ensemble Learning Model Predicts Pathological Response and Treatment Outcomes to Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Pretreatment CT Images: A Multicenter, Retrospective Cohort Study

  Speaker: Yunsong Liu, MD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing
• 02:30pm - 03:45pm PT

  A Preliminary Investigation into the Clinical Application of Magnetic Resonance Linear Accelerator for Treating Hepatocellular Carcinoma and Colorectal Cancer Liver Metastasis

  Speaker: Yuan Zong, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 02:30pm - 03:45pm PT

  A Prospective Study of CT-Guided and 3D-Printing Template-Assisted Implantation of Fiducial Markers in the Pancreatic Carcinoma for Stereotactic Body Radiation Therapy (FIRST-1 Study)

  Speaker: Yi Chen, MD - Peking University Third Hospital, Beijing
• 02:30pm - 03:45pm PT

  Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center

  Speaker: Jing Wang, MD, PhD - Chinese PLA General Hospital, Beijing
• 02:30pm - 03:45pm PT

  Achievable Dosimetry for the Anterior Vaginal Wall and Bulboclitorus with Vaginal Dilator Use in Pelvic Radiotherapy for Anal and Rectal Cancers

  Speaker: Aoi Shimomura, MD - Cedars-Sinai Medical Center, Los Angeles
• 02:30pm - 03:45pm PT

  Analysis of Treatment Patterns and Prognostic Factors in Patients with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma

  Speaker: Hanyu Si, MD, MB - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang City
• 02:30pm - 03:45pm PT

  Analysis of Urgent Starts for Radiotherapy that Occur on Weekends at an Academic Institution

  Speaker: Matthew Charles, MD - University of Wisconsin Hospitals and Clinics, Madison
• 02:30pm - 03:45pm PT

  Association of Central Hepatobiliary Tract Radiation Dose and Hepatobiliary Outcomes after MRI-Guided Liver Stereotactic Body Radiotherapy

  Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 02:30pm - 03:45pm PT

  Association of Skeletal Muscle and Adiposity Measured by Computed Tomography with Toxicity and pCR in Esophageal Squamous Cell Carcinoma Receiving Standardized Neoadjuvant Chemoradiotherapy

  Speaker: Wei-Xiang Qi, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
• 02:30pm - 03:45pm PT

  Barriers and Facilitators to Anal Cancer Screening and Treatment for Patients with HIV: Physician Perceptions and Practices

  Speaker: Kara Rolle, BS, MPH - Emory University, Atlanta
• 02:30pm - 03:45pm PT

  Bone Marrow-Sparing Radiotherapy could Limit or Avoid Radiation Induced Lymphopenia and Thrombocytopenia in Esophageal Cancer Patients after Neoadjuvant Chemoradiotherapy

  Speaker: Mathew Gorman, MD - Cross Cancer Institute, Edmonton
• 02:30pm - 03:45pm PT

  Breaking the Stigma: Oncology Providers Weigh in on Psychedelic-Assisted Therapy

  Speaker: Akul Munjal, MD - UC Irvine Health, Orange
• 02:30pm - 03:45pm PT

  Carbon-Ion Radiotherapy for Elderly Patients with Locally Advanced Pancreatic Cancer

  Speaker: Kotaro Terashima, MD, PhD - Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu
• 02:30pm - 03:45pm PT

  Cardiomyocytes Upregulated the PD-L1 Expression to Alleviate Cardiac Injury Induced by Irradiation Combined with Anti-PD-1 Antibody: An In Vitro and In Vivo Study

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Changes in Apparent Diffusion Coefficient After Radiation Therapy for Bone Metastases: A Comparative Study of SBRT and Conventional RT

  Speaker: Osamu Tanaka, MD, PhD - Asahi Univeristy Hospital, Gifu city
• 02:30pm - 03:45pm PT

  Chronotherapeutic Effects of Immune Checkpoint Inhibitors and Stereotactic Body Radiotherapy: Secondary Analysis of a Prospective Trial

  Speaker: Aashka Mehta, - University of Chicago Medicine, Chicago
• 02:30pm - 03:45pm PT

  Circulating Tumor DNA Dynamics as Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma (ESCC) Receiving Definitive Radiotherapy: A Prospective Cohort Study

  Speaker: Rutian Cheng, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Cistern-Guided Radiosurgery: Personalized Dose Adaptation for Young Medically Refractory Trigeminal Neuralgia Patients

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai
• 02:30pm - 03:45pm PT

  Clinical and Dosimetric Predictors for Radiation-Induced Acute Upper Gastrointestinal Bleeding in Patients with Hepatocellular Carcinoma Undergoing Proton or Photon Radiation Therapy

  Speaker: Willy, Po-Yuan Chen, MD - Linkou Chang Gung Memorial Hospital, Taoyuan
• 02:30pm - 03:45pm PT

  Clinical Application of Simultaneous Integrated Boost in Stereotactic Body Radiotherapy for Large-Volume Tumors: A Single-Center Retrospective Study

  Speaker: Min Zhao, MD - The First Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Clinical Benefit of Adding Irinotecan to Standard Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis

  Speaker: Botian Zhao, MD - The Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Clinical Benefits of Postoperative Adjuvant Immunotherapy for Resectable Locally Advanced Esophageal Cancer

  Speaker: Cong Li, - Chongqing University Cancer Hospital, Chongqing
• 02:30pm - 03:45pm PT

  Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia

  Speaker: Yifu Ma, - The Second Affiliated Hospital of Soochow University, Suzhou
• 02:30pm - 03:45pm PT

  Clinical Outcomes and Patterns of Failures of Patients with Oligometastatic Anal Squamous Cell Carcinoma Treated with Definitive-Intent Chemoradiation and Metastasis-Directed Therapy

  Speaker: Revathi Ravella, MD - Memorial Sloan Kettering Cancer Center, New York
• 02:30pm - 03:45pm PT

  Clinical Outcomes and Safety of the Combination of External Beam Radiotherapy with ¹⁷⁷Lu-DOTATATE

  Speaker: Abigail Pepin, MD - University of Pennsylvania Health System, Philadelphia
• 02:30pm - 03:45pm PT

  Clinical Outcomes of SBRT for Oligometastatic Bone Disease and the Risk Factor of Local Recurrence

  Speaker: Katsuyuki Shirai, MD, PhD - Jichi Medical University Hospital, Shimotsuke
• 02:30pm - 03:45pm PT

  Combining Lu177-PSMA and External Beam Radiation Therapy: A Retrospective Safety Analysis

  Speaker: Desiree Rafizadeh, BS - UCI School of Medicine, Orange
• 02:30pm - 03:45pm PT

  Treatment Outcomes and Prognostic Factors in Young-Onset Rectal Cancer

  Speaker: Daniel Hong, MD - Washington University in St. Louis, St. Louis
• 02:30pm - 03:45pm PT

  Comparative Effectiveness of Neoadjuvant Chemoradiotherapy vs. Chemoimmunotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study

  Speaker: Hong Ge, MD - Henan Cancer Hospital, Zhengzhou
• 02:30pm - 03:45pm PT

  Comparative Evaluation of Quality of Life with EORTC-CR29 QoL Questionnaire between Nonoperative Management and Surgical Patients Following Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer

  Speaker: Ugur Selek, MD, FASTRO, Prof. - Koc University, School of Medicine, Istanbul, Turkey, Istanbul
• 02:30pm - 03:45pm PT

  Comparing Stereotactic Body Radiation Therapy and Hypofractionated Radiation for Unresectable Intrahepatic and Perihilar Cholangiocarcinoma: A Retrospective Analysis

  Speaker: Bryn Myers, MD - Cleveland Clinic Foundation, Cleveland
• 02:30pm - 03:45pm PT

  Correlation between Adverse Events Therapeutic Response and Microbiome Changes

  Speaker: Kristof Gal, MD, PhD - University of Debrecen, Debrecen
• 02:30pm - 03:45pm PT

  Correlation between Pan-Immune Inflammation Value Dynamics and Magnetic Resonance Imaging Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy

  Speaker: Ugur Selek, MD, FASTRO, Prof. - Koc University, School of Medicine, Istanbul, Turkey, Istanbul
• 02:30pm - 03:45pm PT

  Cost-Effectiveness of Comprehensive Metastasis Directed Therapy in Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma

  Speaker: Anna Dornisch, MD - UC San Diego, La Jolla
• 02:30pm - 03:45pm PT

  CoVART: A Retrospective Cohort Study of Conventionally Fractionated RT vs. Ablative RT Dosing in the Treatment of Locally Advanced Pancreatic Cancer

  Speaker: Elizabeth Ademuwagun, MD - Temple University Hospital/Fox Chase Cancer Center, Philadelphia
• 02:30pm - 03:45pm PT

  CT-Based Target Delineation and Low-Dose Radiotherapy for Knee Osteoarthritis - A Single Center Experience

  Speaker: Yu-Hsuan Chuang, MD - Far Eastern Memorial Hospital, New Taipei City
• 02:30pm - 03:45pm PT

  Deep and Durable Prostate-Specific Antigen Response Following Comprehensive Involved Site Radiotherapy for Prostate Cancer Oligometastases

  Speaker: Megha Schmalzle, BS - New York Institute of Technology College of Osteopathic Medicine, Old Westbury
• 02:30pm - 03:45pm PT

  A CRM-Integrated ypT Staging System Improves Prognostic Stratification Following Neoadjuvant Therapy in Rectal Cancer

  Speaker: Wan-Hsuan Chow, MD - Chi Mei Medical Center, Yungkang City 701 44
• 02:30pm - 03:45pm PT

  Development and Analysis of a Nomogram Based on Prognostic Factors in Locally Advanced Esophagogastric Junction Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Development and Evaluation of a Protocol for Managing Hyperkalemia in Patients with Metastatic Neuroendocrine Tumor Treated with Radiopharmaceuticals

  Speaker: Nitika Thawani, MD - UACC, Paradise Valley
• 02:30pm - 03:45pm PT

  Development and Validation of a Predictive Nomogram for Abdominal Lymph Node Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma: Insights from a Multicenter Study

  Speaker: Wei Huang, MD, PhD - Shandong Cancer Hospital, Jinan
• 02:30pm - 03:45pm PT

  Differential Dose-Volume Indices-Based Machine Learning Model for Severe Radiation-Induced Lymphopenia in Patients with Upper Abdominal Malignancies

  Speaker: Yuanlin Li, MS - Shandong Cancer Hospital and Institute, Jinan
• 02:30pm - 03:45pm PT

  Does Thoracic Radiotherapy Combined with Immune Checkpoint Inhibitors Increase Cardiac Toxicity? — A Systemic Review and Meta-Analysis

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Dose Accumulation and Geometric Variation of Local Recurrence in Anal Cancer Patients Receiving Concurrent Chemoradiation

  Speaker: Jasmine Chen, MS, RT - Princess Margaret Cancer Centre, Toronto
• 02:30pm - 03:45pm PT

  Dose-Volume Constraints Associated with Liver Toxicity in Patients with Small Livers Receiving Liver Stereotactic Body Radiation Therapy

  Speaker: Eric Hsu, MD, PhD - Stanford Health Care, Stanford
• 02:30pm - 03:45pm PT

  Dosimetric Comparison of Carbon Ion Beam Therapy and SBRT for Ventricular Arrhythmia

  Speaker: Mayumi Ichikawa, MD, PhD - Yamagata University School of Medicine, Yamagata
• 02:30pm - 03:45pm PT

  Durable Clinical Response Following Radiosurgery for Trigeminal Neuralgia is Predicted by Volumetric Dose Distribution to the Cisternal Portion of the Nerve

  Speaker: Muhammad Shohayeb, MD, MBChB - UPMC Cancer Center, Pittsburgh
• 02:30pm - 03:45pm PT

  Durable Local Control of Adding Palliative Radiotherapy to Nivolumab for Advanced Esophageal Cancer

  Speaker: Takeshi Fujisawa, MD, PhD - National Cancer Center Hospital East, Kashiwa-shi
• 02:30pm - 03:45pm PT

  Early Clinical Results of Spatially Fractionated Radiation Therapy (SFRT) with GRID in the Treatment of Bulky/Advanced Tumors

  Speaker: Natalie Wong, MBBS, MRes(Med), FRCR - Tuen Mun Hospital, Hong Kong
• 02:30pm - 03:45pm PT

  Early Outcomes of Dose-Escalated Radiation Therapy for Pancreatic Cancer

  Speaker: I-Chia Liu, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore
• 02:30pm - 03:45pm PT

  Effect of Prophylactic Thrombopoietin and Magnetic Resonance Guided Bone Marrow-Sparing Concurrent Chemoradiotherapy on Thrombocytopenia for Thoracic Esophageal Cancer: Final Analysis of a Phase II Study

  Speaker: Yupei Yuan, MD, MS - Cancer Hospital Chinese Academy of Medical Sciences, Beijing
• 02:30pm - 03:45pm PT

  Effect of Same-Day Volumetric Modulated Arc Therapy on Resource Utilization in Rapid Access Palliative Radiotherapy Clinics Using a Radiation Oncologist-Initiated Automated Planning Script

  Speaker: Emily O'Reilly, MD, BS - BC Cancer - Vancouver Centre, Vancouver
• 02:30pm - 03:45pm PT

  Efficacy and Safety of Neoadjuvant Therapies in Locally Advanced Esophageal Squamous Cell Carcinoma: A Comprehensive Retrospective Analysis

  Speaker: Likun Liu, MD - Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Efficacy and Safety of Stereotactic Intensity-Modulated Proton Therapy (SIMPT) in Unresectable Hepatocellular Carcinoma

  Speaker: Thinnakorn Chomchai, MD - King Chulalongkorn Memorial Hospital, Bangkok
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy (SBRT) to Sites of Oligoprogression during Lutetium-177-PSMA-617 (Lu-PSMA) Treatment for Metastatic Castrate Resistant Prostate Cancer

  Speaker: Adam Kessel, MD - Mayo Clinic Rochester, Rochester
• 02:30pm - 03:45pm PT

  Trends in Local Therapy for Hepatocellular Carcinoma from 2004-2019: An NCDB Analysis

  Speaker: Benjamin Tran, MD - Mount Sinai Hospital, New York
• 02:30pm - 03:45pm PT

  Ending the HIV Epidemic with Low Dose Total Body Irradiation in Combination with Anti-Microtubule Therapy

  Speaker: Kati Doxsee, PhD - Prisma Health- Upstate Cancer Institute, Greenville
• 02:30pm - 03:45pm PT

  Endobronchial HDR Brachytherapy for Post-Transplant or Wegener's Granulomatosis Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function, Subsequent Procedures, and Second Malignancy

  Speaker: Abigail Groszkiewicz, MD - University of Pittsburgh Medical Center, Pittsburgh
• 02:30pm - 03:45pm PT

  Escalated-Dose Ablative Radiation Therapy for Oligometastatic Pancreatic Cancer: A Single-Institution Experience

  Speaker: Mustafa Basree, DO, MS - University of Wisconsin Hospitals and Clinics, Madison
• 02:30pm - 03:45pm PT

  Evaluating KPIs in Palliative Care: Insights from a Tertiary Center

  Speaker: Nandan Shanbhag, MD - Tawam Hospital, Abu Dhabi
• 02:30pm - 03:45pm PT

  Evaluation of Short-Term Efficacy and Long-Term Prognostic Factors following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer

  Speaker: Linlin Xiao, MS, RT - the fourth hospital of hebei medical university, Shijiazhuang
• 02:30pm - 03:45pm PT

  Exercise Enhancement after Radiotherapy for Bone Metastases: A Phase I Feasibility Trial for Patients with Painful Non-Spine Bone Metastases (EXERT-BM)

  Speaker: Michael Yan, MD - Princess Margaret Cancer Center, University Health Network, Toronto
• 02:30pm - 03:45pm PT

  Exploratory Analysis of PET and CA 19-9 Response in Pancreatic Ductal Adenocarcinoma Outcomes: A Secondary Analysis of a Prospective Phase 2 Trial

  Speaker: Keaton Rummel, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester
• 02:30pm - 03:45pm PT

  Extended-Field Definitive Chemoradiation for Patients with Anal Squamous Cell Carcinoma with Nodal Metastatic Disease

  Speaker: Elisa Liu, MD, BS - Memorial Sloan Kettering Cancer Center, New York
• 02:30pm - 03:45pm PT

  External Beam Radiotherapy (EBRT) + Immunotherapy (IO) in the Management of Hepatobiliary Malignancies: A Meta-Analysis of Treatment Response Rates

  Speaker: Juan Jose Juarez Vignon Whaley, MD - MetroWest Medical Center, Sudbury
• 02:30pm - 03:45pm PT

  FAP-Targeted PET/CT with [18F]AlF-NOTA-FAPI-04 in Hepatocellular Carcinoma: Prospective Correlation of Fibrosis Quantification with Treatment Response and Survival Outcomes

  Speaker: Chen Wang, MD - Shandong Cancer Hospital and Institute, Jinan
• 02:30pm - 03:45pm PT

  Feasibility and Safety of Black Soybean Extract Cream on Radiation-Induced Dermatitis, Pain and Quality of Life in Head and Neck Cancer Patients: A Phase I, Single-Arm, Open-Label Prospective Study

  Speaker: Hain-Hua Lee, MD - Kaohsiung Medical University, Kaohsiung City
• 02:30pm - 03:45pm PT

  Feasibility of 3 Fraction Treatment Using Stereotactic Magnetic Resonance - Guided Adaptive Radiation Therapy in Single or Three Fractions for Oligometastases in the Abdomen and Pelvis: Results from the Phase I SMART-STOP 3-Fraction Cohort

  Speaker: Zoe Cosner, MD - Harvard Radiation Oncology Program, Boston
• 02:30pm - 03:45pm PT

  Feasibility of Serial Tumor-Informed ctDNA Testing to Assess Response to Chemoradiation in Esophageal Cancer

  Speaker: Abraham Wu, MD - Memorial Sloan Kettering Cancer Center, New York
• 02:30pm - 03:45pm PT

  Four-Year Results of a Phase I/II Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases

  Speaker: Thomas Howard, MD, PhD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston
• 02:30pm - 03:45pm PT

  Fractionated Stereotactic Radiotherapy in People with Drug-Resistant Focal Epilepsy: First-In-Human Experience with a Healthy Tissue-Preserving Dose-Fractionation Concept

  Speaker: Davide Scafa, MD - UKB Bonn, Bonn
• 02:30pm - 03:45pm PT

  A Non-Invasive Stereotactic Mimicking Radiosurgery with a Frameless Robotic Radiosurgery: A Comparison of Dose Prescription Methodologies for Treatment of Trigeminal Neuralgia

  Speaker: Alan Monroe, MD - Penrose Cancer Center, Colorado Springs
• 02:30pm - 03:45pm PT

  Gut Microbiome and Metabolic Traits in Immunotherapy-Based Total Neoadjuvant Therapy for MSS Locally Advanced Rectal Cancer: A Longitudinal Cohort Study

  Speaker: Weiqing Lu, PhD, MS - Fudan University Shanghai Cancer Center, Shanghai
• 02:30pm - 03:45pm PT

  Heel Spur Radiotherapy: Prospective Randomized Clinical Trial

  Speaker: Petr Burkon, MD, PhD - Masaryk Memorial Cancer Institute, Brno
• 02:30pm - 03:45pm PT

  Hepatobiliary Toxicity following Ablative Radiation for Centrally Located Hepatocellular Carcinoma (HCC)

  Speaker: Sarah Feldkamp, MD - University of Cincinnati, Cincinnati
• 02:30pm - 03:45pm PT

  High Rates of Local Failure in the Triangle Volume for Non-Irradiated Borderline Resectable and Locally Advanced Pancreatic Cancer

  Speaker: I-Chia Liu, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore
• 02:30pm - 03:45pm PT

  Hypofractionated Pelvic Radiotherapy for Symptom Control in Metastatic Rectal Cancer: A Retrospective Analysis

  Speaker: Ningyu Wang, MD - Cancer center of China, Beijing
• 02:30pm - 03:45pm PT

  Hypofractionated Radiotherapy Combined with Immunotherapy and Chemotherapy for Locally Recurrent Rectal Cancer (TORCH-R): A Prospective, Single-Arm, Two-Cohort, Phase II Trial

  Speaker: Ruiyan Wu, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
• 02:30pm - 03:45pm PT

  ICD Coding an 3D Target Volume Definitions for Benign Diseases: An International Delphi Consensus Process

  Speaker: Heinrich Seegenschmiedt, MD, PhD, Professor - ergea MVZ Strahlentherapie Aalen, Aalen
• 02:30pm - 03:45pm PT

  Identifying Risk Factors and Evaluating Therapeutic Interventions for Anastomotic Recurrence in Postoperative Esophageal Squamous Cell Carcinoma

  Speaker: Wei Huang, MD, PhD - Shandong Cancer Hospital, Jinan
• 02:30pm - 03:45pm PT

  Impact of Elective Nodal Irradiation (ENI) vs. Involved Field Irradiation (IFI) on Estimated Dose Radiation to Immune Cells (EDRIC) and Prognostic Analysis in Esophageal Carcinoma

  Speaker: Xuejiao Ren, MD - Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Impact of HRD Status and DDR Pathway Genes on Chemoradiotherapy Effectiveness in Chinese Esophageal Cancer Patients

  Speaker: Jingping Yu, PhD, none - Changzhou Cancer Hospital, Changzhou
• 02:30pm - 03:45pm PT

  Impact of Muscle Mass Loss on Survival during Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-Center Retrospective Study in China (TIMES Study)

  Speaker: Jie Zhu, MD - Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan, Chengdu
• 02:30pm - 03:45pm PT

  Impact of Preoperative Ablative Radiation after Induction Chemotherapy for Borderline Resectable Pancreatic Adenocarcinoma

  Speaker: Alden D'Souza, MD, MPHS - Washington University School of Medicine, Saint Louis
• 02:30pm - 03:45pm PT

  Impact of Prior Primary Care Utilization on Metastatic Disease and Mortality in Colorectal Cancer

  Speaker: Sakshith Reddy Chintala, MS - University of California San Diego Health, San Diego
• 02:30pm - 03:45pm PT

  Impact of Radiation Therapy on Survival in Hepatocellular Carcinoma with Vascular Tumor Thrombus: A Retrospective Analysis of Systemic Therapy Combinations

  Speaker: Rafi Kabarriti, MD - Montefiore Medical Center, Bronx
• 02:30pm - 03:45pm PT

  Impact of Stomatitis on the Efficacy of QUAD SHOT for Head and Neck Cancer: A Prospective Study

  Speaker: Osamu Tanaka, MD, PhD - Asahi Univeristy Hospital, Gifu city
• 02:30pm - 03:45pm PT

  Impact of Subcutaneous Adipose Tissue Area Change during Neoadjuvant Chemoradiotherapy on Disease-Free Survival and Tumor Response in Patients with Locally Advanced Rectal Cancer

  Speaker: Qing Yang, - Department of General Surgery, Peking University Third Hospital, Beijing, China, Beijing
• 02:30pm - 03:45pm PT

  Impact of Subcutaneous and Visceral Fat in Patients Receiving Ablative Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Cancer

  Speaker: Adeel Kaiser, MD - Miami Cancer Institute, Miami
• 02:30pm - 03:45pm PT

  Impact of the NRF-2/KEAP-1 Signaling Pathway on Treatment Response in Rectal Cancer Patients Treated with Neoadjuvant Chemo-Radiotherapy

  Speaker: Hatice Kubra Gunduz, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul
• 02:30pm - 03:45pm PT

  Impact of Time to Treatment on the Development of Distant Metastasis in Localized Pancreatic Cancer: A Tertiary Care Center Experience.

  Speaker: Bhupesh Parashar, MD, PhD - Northwell Health/Zucker school of Medicine at Hofstra, Lake Success
• 02:30pm - 03:45pm PT

  Improving Dysphagia Relief and Patient Throughput in Advanced Esophageal Cancer with Brachytherapy in Resource-Limited Settings

  Speaker: Ajay Choubey, MBBS, DNB - Homi Bhabha Cancer Hospital and Research Centre, varanasi
• 02:30pm - 03:45pm PT

  Incorporating Electroanatomic Mapping Data into Radiation Treatment Planning for Stereotactic Cardiac Radioablation: A One-Year Follow-up

  Speaker: Khashayar Fattah, MD - University of Texas Southwestern Medical Center, Dallas
• 02:30pm - 03:45pm PT

  Influence of Pancreatic Ductal Adenocarcinoma Anatomic Tumor Subregion on Oncologic Outcomes Following MRI-Guided Stereotactic Body Radiotherapy

  Speaker: Rojine Ariani, MD, MS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 02:30pm - 03:45pm PT

  Initial Clinical Results of Four-Dimensional CT-Guided Online Adaptive Radiotherapy for Advanced Gastric Cancer

  Speaker: Hong Ma, MD, PhD - Tongji Hospital Affiliated to Tongji Medical College of Huazhong University, Wuhan
• 02:30pm - 03:45pm PT

  Inpatient Radiotherapy: Insights for Hemostasis Consults

  Speaker: Simran Polce, MD - Moffitt Cancer Center, Tampa
• 02:30pm - 03:45pm PT

  Insights and Impact of a Dedicated Inpatient Radiation Oncology Service

  Speaker: Emily Keit, MD - Moffitt Cancer Center, Tampa
• 02:30pm - 03:45pm PT

  Integration of Dose, Imaging Biomarkers, and 3D Topological Information via Transformer-GNN for Multimodal Learning in Predicting Radiation-Induced Lung Injury in Elderly Esophageal Cancer Patients

  Speaker: Xin Yang, MS - Chongqing University Cancer Hospital, Shapingba
• 02:30pm - 03:45pm PT

  International Consensus on Palliative Radiotherapy Endpoints for Bone Metastases Trials: Second Update

  Speaker: Eva Oldenburger, MD, PhD - UZ Leuven, Leuven
• 02:30pm - 03:45pm PT

  International Delphi Consensus on Endpoints Selection, Reporting, and Clinical Response Criteria for SBRT in Bone Metastases

  Speaker: Shing Fung Lee, MBBS - National University Health System, Singapore
• 02:30pm - 03:45pm PT

  Jianzhong Qushi Formula for Treating Chronic Radiation Induced Proctitis with Deficiency Syndrome: A Protocol for a Multicenter, Prospective, Randomized Controlled Clinical Trial (ACORN STUDY)

  Speaker: Yiyuan Cui, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 02:30pm - 03:45pm PT

  KRAS Mutations as Predictor of Radioresistance in Pulmonary Metastases from Colorectal Cancer

  Speaker: Mauro Loi, MD, PhD - Azienda Ospedaliera Universitaria Careggi, Florence
• 02:30pm - 03:45pm PT

  Laboratory and Dosimetric Predictors for Short Term Survival and Toxicity for HCC Patients Treated with SBRT

  Speaker: Seyyedeh Azar Oliaei Motlagh, - University of Michigan, Ann Arbor
• 02:30pm - 03:45pm PT

  LINAC-based Stereotactic Ablative Radiotherapy (SABR) for Pancreatic Cancer: Toxicity Profile and Outcomes

  Speaker: Yen-Ruh Wuu, MD - Northwell Health, Lake Success
• 02:30pm - 03:45pm PT

  Long-Term Outcomes of Intraoperative Electron Radiotherapy (IOERT) in Locally Advanced and Recurrent Colorectal Cancer: A Single-Institution Experience

  Speaker: Abdullah Alswilem, MBBS - King Saud University Medical City, Riyadh
• 02:30pm - 03:45pm PT

  Low Dose Cytokine Modulation and Anti-Inflammatory Radiotherapy in Osteoarthritis: Pioneering Pain Relief and Enhanced Quality of Life - First-of-Its-Kind Study in the Subcontinent

  Speaker: G Lohith, MD - HCG,
• 02:30pm - 03:45pm PT

  Low Dose Radiation Therapy (LDRT) for Osteoarthritis: A Retrospective Study of 59 Patients and 94 Joints Treated

  Speaker: Nayan Shah, - University of Florida, Gainesville
• 02:30pm - 03:45pm PT

  Low Dose Radiotherapy in Treatment of Recalcitrant Hidradenitis Suppurativa

  Speaker: Robert Walker, MD, MS - Thomas Jefferson University, Philadelphia
• 02:30pm - 03:45pm PT

  Low-Dose Radiotherapy for Interstitial Cystitis

  Speaker: Michael Nolan, DVM, PhD - North Carolina State University, Raleigh
• 02:30pm - 03:45pm PT

  Low-Dose Radiotherapy for Painful Musculoeskeltal Disorders: 10 Years Follow-Up

  Speaker: Maria del Carmen Saiz, MD - UCLH, London
• 02:30pm - 03:45pm PT

  Maximizing Survival Benefits with Precision Therapy Based on Progressive Patterns after First-Line Immunochemotherapy Failure in Metastatic Esophageal Cancer: A Retrospective Multicenter Study

  Speaker: Yingnan Liu, - Shandong Cancer Hospital, Jinan
• 02:30pm - 03:45pm PT

  Modest Dose Escalation for Early-Stage Anal Cancer: Cancer Control and Toxicity Outcomes

  Speaker: Sage Copling, BS - MD Anderson Cancer Center, Houston
• 02:30pm - 03:45pm PT

  MR-Guided Adaptive Radiotherapy for Primary Liver Cancer: Impact of Online Isotoxic Prescriptions near Organs-at-Risk

  Speaker: Haruo Inokuchi, MD, PhD - osaka metropolitan university, Osaka-city
• 02:30pm - 03:45pm PT

  MR-Guided Adaptive Stereotactic Ablative Radiotherapy for Postoperative Recurrent and Metastatic Pancreatic Cancer: Early Efficacy and Toxicity Outcomes

  Speaker: Chen Wang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
• 02:30pm - 03:45pm PT

  MRI-Simulator and MR-Linac in Esophageal and Gastric Cancers: An Imaging-Pathology Correlation Study

  Speaker: Su Chen Fong, MBBS - Peter MacCallum Cancer Centre, Melbourne
• 02:30pm - 03:45pm PT

  Multivariate Analysis of Outcomes of Palliative Radiotherapy and Re-Irradiation in Children

  Speaker: Faisal Habbab, MBBS - Cross Cancer Institute, Edmonton
• 02:30pm - 03:45pm PT

  Neo-Adjuvant Radiotherapy Induced Pelvic Bone Marrow FDG PET Uptake Difference to Predict Chemotherapy Related Hematologic Toxicity in Rectal Cancer Patients

  Speaker: Gulsah Ozden, MD - Marmara University, Istanbul
• 02:30pm - 03:45pm PT

  Neoadjuvant Therapy Approaches for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  Speaker: Chia Ching Lee, MD - National University Cancer Institute Singapore, Singapore
• 02:30pm - 03:45pm PT

  Neuroanatomical Synergy in Cyberknife Stereotactic Ablative Neuromodulation: Revisiting Contouring Paradigms with Dopamine PET-CT and Fgatir MRI for Ventral Intermediate Nucleus Targeting in Parkinson's Disease for Improved Outcomes — A Subcontinental Fir

  Speaker: G Lohith, MD - HCG,
• 02:30pm - 03:45pm PT

  Neuropsychological Screening, Advance Care Planning, and End-of-Life Care among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

  Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston
• 02:30pm - 03:45pm PT

  Neurostructural Paradox in Trigeminal Neuralgia: VBM Reveals Pain Network Remodeling after Radiosurgery

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai
• 02:30pm - 03:45pm PT

  Non-Surgical Management of Rectal Adenocarcinoma in a Safety-Net Hospital System: Outcomes and Implications for Watch and Wait Strategies

  Speaker: Ashley Chavana, BS - Baylor College of Medicine, Houston
• 02:30pm - 03:45pm PT

  Oncological Outcomes of Dose-Escalated Chemoradiotherapy vs. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Analysis

  Speaker: Abdullah Alswilem, MBBS - King Saud University Medical City, Riyadh
• 02:30pm - 03:45pm PT

  Opioid-Related Hospitalizations and Benzodiazepine Co-Prescription in Older Cancer Survivors

  Speaker: Sakshith Reddy Chintala, MS - University of California San Diego Health, San Diego
• 02:30pm - 03:45pm PT

  Optimization of Radiotherapy Modality in Elderly Esophageal Cancer Patients: A Decade-Long Retrospective Survival Analysis

  Speaker: Yan Luo, PhD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 02:30pm - 03:45pm PT

  Optimizing Palliative Radiotherapy: Analysis of Workflow and Efficiency of a Dedicated Rapid-Access Palliative and Oligometastatic Radiotherapy Program

  Speaker: Amiya Agrawal, MD, MBBS - Tata Memorial Hospital, Mumbai
• 02:30pm - 03:45pm PT

  Organ Preservation in Locally Advanced Rectal Cancer Treated with Contact X-Ray Brachytherapy: A Systematic Review and Single-Arm Meta-Analysis

  Speaker: Adriana Dominguez Ayala, MD - ISSSTE, Mexico City
• 02:30pm - 03:45pm PT

  Outcomes in Borderline Resectable Pancreatic Cancer: Impact of Integrated Pathologic Score

  Speaker: Torrin Jacobsen, MS, BS - Lake Erie College of Osteopathic Medicine Bradenton, Tampa
• 02:30pm - 03:45pm PT

  Outcomes of Extensive-Stage Small-Cell Esophagus Cancer Patients Treated with Different Treatment Modalities: A Multi-Institutional Retrospective Analysis

  Speaker: Wei Huang, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan
• 02:30pm - 03:45pm PT

  Outcomes of Re-Irradiation with Pencil Beam Scanning Proton Therapy for Rectal Cancer Following Prior Pelvic Radiation: Toxicity, Recurrence, and Symptom Improvement

  Speaker: Austin Thompson, MD - University of Maryland Medical Center, Baltimore
• 02:30pm - 03:45pm PT

  Pain Response to Palliative Radiation Therapy in Korean American Cancer Patients with Metastases to Bone

  Speaker: Iris Kang, BS - Keck School of Medicine of USC, Los Angeles
• 02:30pm - 03:45pm PT

  Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns

  Speaker: Van Handke, EMT - MD Anderson Cancer Center, Houston
• 02:30pm - 03:45pm PT

  Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability and Clinical Outcomes

  Speaker: Helen Hou, - Massachusetts General Hospital, Boston
• 02:30pm - 03:45pm PT

  Perioperative Radiation Therapy for Prevention of Recurrent Arthrofibrosis after Revision Total Knee Arthroplasty

  Speaker: Jason Liu, BS - UCF College of Medicine, Orlando
• 02:30pm - 03:45pm PT

  Phase II Trial of Autologous Lymphocyte Infusions after Radiotherapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients with Solid Tumor Malignancies

  Speaker: Enoch Chang, MD - MD Anderson Cancer Center, Houston
• 02:30pm - 03:45pm PT

  Phased Relief: Optimizing Dose for Bilateral Trigeminal Neuralgia Radiosurgery

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai
• 02:30pm - 03:45pm PT

  Piloting the Role of an Advanced Practice Radiation Therapist to Relieve Stress on Radiation Oncologists, Increase Productivity, and Improve Care for Patients Needing Urgent Palliative Radiation

  Speaker: Danielle McDonagh, DSc, MS, RT - Mount Sinai Hospital, New York
• 02:30pm - 03:45pm PT

  PIVKA-II as an Adjunct Biomarker to AFP for the Assessment of the Early Radiographic Treatment Response to SBRT in HCC

  Speaker: Srinjoy Sil, MD, PhD - NYU Langone Medical Center, New York
• 02:30pm - 03:45pm PT

  PLDR Chemoradiation for Esophageal and Lung Cancer is Associated with Low Rates of Severe Esophagitis

  Speaker: Joshua Meyer, MD, FASTRO - Fox Chase Cancer Center, Philadelphia
• 02:30pm - 03:45pm PT

  Individualized Pancreatic Cancer Prevention: A Machine Learning Approach Integrating Polygenic Risk Scores for Absolute Risk Prediction in UK Biobank and Community Settings

  Speaker: Te-Min Ke, MD, PhD - Chi Mei Medical Center, Yungkang City 701 44
• 02:30pm - 03:45pm PT

  Predicting Pathologic Complete Response following Clinical Complete Response in Esophageal Carcinoma

  Speaker: Mihir Karande, MD - Fox Chase Cancer Center, Philadelphia
• 02:30pm - 03:45pm PT

  Predictors of Pathologic and Radiologic Response in Patients with HCC Treated with SBRT Prior to Transplant

  Speaker: Evrosina Isaac, MD - Virginia Commonwealth University Health System, Richmond
• 02:30pm - 03:45pm PT

  Pre-Treatment Cardiovascular Risk Profile in Esophageal Cancer Patients: A Comparative Analysis with Other Thoracic Malignancies

  Speaker: Akinori Takada, MD, PhD - Mie university, Tsu
• 02:30pm - 03:45pm PT

  Prognostic Predictive Role of Short-Term Efficacy Indicators in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

  Speaker: Ningyu Wang, MD - Cancer center of China, Beijing
• 02:30pm - 03:45pm PT

  Proton Radiotherapy Alone vs. Combined with Immuno-Oncology Agents (Proton-IO) or Tyrosine Kinase Inhibitors (Proton-TKI) for Intermediate to Advanced-Stage Hepatocellular Carcinoma

  Speaker: Rodney Cheng-En Hsieh, MD, PhD - Chang Gung Memorial Hospital Linkou Branch, Taoyuan City
• 02:30pm - 03:45pm PT

  PSMA-PET Guided Metastasis-Directed Therapy

  Speaker: Elitza Koutleva, MD, MBA - University of North Carolina at Chapel Hill, Chapel Hill
• 02:30pm - 03:45pm PT

  Quality of Life Assessment of Palliative Radiotherapy for Patients with Low-Risk Asymptomatic Bone Metastasis: A Prospective Observational Study

  Speaker: Yutaro Koide, MD, PhD - Aichi Cancer Center Hospital, Nagoya
• 02:30pm - 03:45pm PT

  Radiation Therapy for Cancer Pain with and without a Neuropathic Component: A Single-Center Prospective Observational Study

  Speaker: Kohsei Yamaguchi, MD, PhD - Ariake medical center, Arao
• 02:30pm - 03:45pm PT

  Radiosurgery Outcomes in Pure Venous Conflict Trigeminal Neuralgia Efficacy, Safety, and Long-term Outcomes

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai
• 02:30pm - 03:45pm PT

  Radiotherapy as an Organ-Preserving Alternative to Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Achieving Major Pathologic Response after Induction Immunochemotherapy

  Speaker: Xin-Yun Song, MD - Shanghai Chest Hospital, Shanghai
• 02:30pm - 03:45pm PT

  Radiotherapy Combined with Systemic Therapy vs. Systemic Therapy Alone for Recurrent or Metastatic Esophageal Cancer: A Systematic Review and Meta-Analysis

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Radiotherapy of Dupuytren's Contracture Following Collagenase Treatment

  Speaker: Colton Cox, BS - University of Nevada Reno School of Medicine, Reno
• 02:30pm - 03:45pm PT

  Radiotherapy-Boosted Thymosin Alpha-1 Based Immunotherapy: A Cutting-Edge Approach to Amplifying Immune Dynamics and Therapeutic Efficacy in Advanced Solid Tumors

  Speaker: Yuehong Kong, - The Second Affiliated Hospital of Soochow University, ???
• 02:30pm - 03:45pm PT

  Rapid Response Palliative Radiotherapy Program (RAPRT): Experience with a Non-Classical Model

  Speaker: Isidora King, MD - Clinica IRAM, Santiago
• 02:30pm - 03:45pm PT

  Reduced Time to Start with Radiotherapy Treatment Using Online Adaptive Radiotherapy without Planning CT Scan: A Prospective Clinical Trial in Patients with Rectal Cancer

  Speaker: Claudia Schuurhuizen, MD, PhD - Erasmus Medical Center, Rotterdam
• 02:30pm - 03:45pm PT

  Reirradiation for Abdominal GastroIntestinal Malignancies: A Systematic Review by the Reirradiation Collaborative Group (ReCOG)

  Speaker: Nauman Malik, MD, MS - Princess Margaret Cancer Centre, Toronto
• 02:30pm - 03:45pm PT

  Reirradiation with SBRT in Radiorecurrent Prostate Cancer ? Impact on Disease Control and Quality of Life Outcomes

  Speaker: Papaiah Susheela Sridhar, MD, DNB - Apollo Cancer centre,Bangalore, Bangalore
• 02:30pm - 03:45pm PT

  Relationship of PD-L1 Status and Outcomes in a Diverse Patient Population with Anal Squamous Cell Carcinoma

  Speaker: Daniel Cherry, MD, MAS - Mount Sinai Hospital, New York
• 02:30pm - 03:45pm PT

  Risk Factors for Lateral Pelvic Lymph Node Metastasis in Rectal Cancer

  Speaker: Özge Duran Can, MD - Celal Bayar University, Faculty of Medicine, Department of Radiation Oncology, Manisa
• 02:30pm - 03:45pm PT

  Risk of Vertebral Compression Fractures after Hypofractionated Spine Stereotactic Body Radiation Therapy

  Speaker: Zhen Li, - Zhongshan People's Hospital, Zhongshan
• 02:30pm - 03:45pm PT

  Role of Intraoperative Radiotherapy in Hepatocellular Carcinoma Following Narrow-Margin Hepatectomy: A Single Institutional Long-Term Follow Up Analysis

  Speaker: Mengyuan Li, MD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing
• 02:30pm - 03:45pm PT

  Sacral and Other Pelvic Bone Fractures Following Short-Course Radiation Therapy and Consolidation Chemotherapy for Rectal Cancer

  Speaker: Panos Papanikolaou, MD - Johns Hopkins Hospital, Baltimore
• 02:30pm - 03:45pm PT

  Safe Delivery of Ablative, Non-Adaptive Pancreas and Elective Nodal RT in Borderline Resectable and Locally Advanced Pancreatic Cancer

  Speaker: Reine Abou Zeidane, MD - University Hospitals Seidman Cancer Center | Case Western Reserve University, Cleveland
• 02:30pm - 03:45pm PT

  Short-Course Radiotherapy, Chemotherapy and Surgery in Rectal Cancer Patients under 50: Recurrence and Survival Outcomes

  Speaker: David Simson, MBBS, DNB - Rajiv Gandhi Cancer Institute & Research Centre, New Delhi
• 02:30pm - 03:45pm PT

  Simulation-Free Single-Fraction Conventional and Stereotactic Radiotherapy for Bone and Soft Tissue Metastases

  Speaker: Joanna Javor, MS, CMD, RT - UHN, Toronto
• 02:30pm - 03:45pm PT

  Stereotactic Ablative MR-Guided Online Adaptive Radiation Therapy (SMART) for Management of Borderline Resectable and Locally Advanced Pancreatic Carcinoma

  Speaker: Neris Dincer, MD - Acibadem Universitesi, Istanbul
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy for Adrenal Metastases: Evaluation of Efficacy and Toxicity Outcomes.

  Speaker: Mohammad Alsmairat, MD - King Hussein Cancer Center, Amman
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy for Ventricular Tachycardia is Safe and Effective: Results from a Large Retrospective Cohort

  Speaker: Keith Cengel, MD, PhD - University of Pennsylvania, Philadelphia
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) with and without Liver Transplant in Patients with Advanced Hepatic Cirrhosis.

  Speaker: Parisa Shamsesfandabadi, MD - Duke University Medical Center, Durham
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy (SBRT) vs. Irreversible Electroporation (IRE) in the Treatment of Locally Advanced Pancreatic Cancer, A Systematic Review and Meta-Analysis Comparing Median Overall Survival and Severe Adverse Events

  Speaker: Deniz Demircioglu, BS - Medical College of Wisconsin, Milwaukee
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiation Therapy with PD-1 Inhibitor for Locally Advanced or Locoregionally Recurrent Pancreatic Cancer (preSPARK-1 Study)

  Speaker: Yi Chen, MD - Peking University Third Hospital, Beijing
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief - SOLAR-P

  Speaker: Stephan Tran, MD, BS, MBS - Sunnybrook Odette Cancer Centre, Toronto
• 02:30pm - 03:45pm PT

  Stereotactic Body Radiotherapy (SBRT) in the Treatment of Oligometastatic Breast Cancer: A Multi-Institutional Feasibility Trial

  Speaker: Elysia Donovan, MD, MS - Juravinski Cancer Centre, Hamilton
• 02:30pm - 03:45pm PT

  Stereotactic Radioablation to Ventricular Tachycardia: Prospective Phase I Study in Asian Country

  Speaker: Mariko Kawamura, MD, PhD - Nagoya University hospital, Nagoya
• 02:30pm - 03:45pm PT

  Study of Relationship between Proton Beam Therapy to Liver Cancers and Persistent Pleural Effusion

  Speaker: Sae Matsumoto, MD - Fukui Prefecture Hospital, Fukui 910-8526
• 02:30pm - 03:45pm PT

  Surgical Outcomes in Locally Advanced Rectal Cancer Following Preoperative Chemoradiation with Simultaneous Integrated Boost (SIB-CRT)

  Speaker: Mauro Loi, MD, PhD - Azienda Ospedaliera Universitaria Careggi, Florence
• 02:30pm - 03:45pm PT

  Systemic Therapy with or without Local Radiotherapy for Advanced Esophageal Carcinoma: A Systematic Review and Meta-analysis

  Speaker: Xiaoxi Chen, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  The Impact of Immunotherapy on Splenomegaly and Thrombocytopenia in Locally Advanced Rectal Cancer Patients Undergoing Total Neoadjuvant Therapy

  Speaker: Yaqi Wang, MD - Fudan University Shanghai Cancer Center, Shanghai
• 02:30pm - 03:45pm PT

  The Impact of Tumor-Induced Nutritional Disorders on the Relationship between G8 Scores and Definitive Radiotherapy Strategies

  Speaker: Ikuno Nishibuchi, MD, PhD - Department of Radiation Oncology, Hiroshima University, Hiroshima
• 02:30pm - 03:45pm PT

  The Importance of Lymphopenia Severity in Anal Cancer Patients Undergoing Definitive Therapy

  Speaker: Dulguun Myagmarsuren, BS - Virginia Tech Carilion School of Medicine, Roanoke
• 02:30pm - 03:45pm PT

  The Predictive Value of Pretreatment Peripheral T-Lymphocyte Subsets for Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma Patients Undergoing Neoadjuvant Chemoradiotherapy: A Prospective Cohort Analysis

  Speaker: Wei-Xiang Qi, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
• 02:30pm - 03:45pm PT

  The Relationship between Liver Metastasis Shrinkage Rate and Quantitative Values in Lu-177 DOTATATE Therapy for Somatostatin Receptor-Positive Neuroendocrine Tumors

  Speaker: Kenta Konishi, MD, PhD - Hamamatsu University School of Medicine, Hamamatsu
• 02:30pm - 03:45pm PT

  Time-Dependent Toxicity Modeling and Local Control in BID Thoracic Reirradiation: Implications for Personalized Radiotherapy

  Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore
• 02:30pm - 03:45pm PT

  To Explore the Efficacy and Safety of Neoadjuvant Chemoradiotherapy in Locally Advanced Colon Cancer: A Systematic Review and Meta-Analysis

  Speaker: Jingyi Sun, RT - The Fourth Hospital of Hebei Medical University, Shijiazhuang
• 02:30pm - 03:45pm PT

  Tracing the Pain Circuits: FCD as a Biomarker for Radiosurgery in Trigeminal Neuralgia

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai
• 02:30pm - 03:45pm PT

  Treatment Patterns and Outcomes in Elderly Patients with Cholangiocarcinoma

  Speaker: Jino Park, MD - University of California Irvine, Orange
• 02:30pm - 03:45pm PT

  Using an Auto-Planned VMAT-TBI Technique for Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Scleroderma (the STAT-2 Trial)

  Speaker: Nataliya Kovalchuk, PhD - Stanford University School of Medicine, Palo Alto
• 02:30pm - 03:45pm PT

  Utility of Screening for Oligometastatic Disease: A Systematic Review

  Speaker: Alysa Fairchild, MD - Cross Cancer Institute, Edmonton
• 02:30pm - 03:45pm PT

  Utilization of 4D-CBCT in lieu of Intra-Hepatic Fiducial Markers for Tumor Localization in Liver SBRT - Description of a Novel Technique and Clinical Outcomes in a Retrospective Cohort

  Speaker: Jacob Oyeniyi, MD - Corewell Health William Beaumont University Hospital, Royal Oak
• 02:30pm - 03:45pm PT

  Utilization Rates of Local Hemostatic Treatments for Gastric Cancer: A Survey Based on a Nationwide Claims Database

  Speaker: Yuki Wada, MD, PhD - Akita University Graduate School of Medicine, Akita
• 02:30pm - 03:45pm PT

  When Less Is More: Reducing the Administration of Inappropriate Radiotherapy to Patients with Very Poor Prognosis

  Speaker: Alok Deshane, MD - MSKCC, New York
• 02:30pm - 03:45pm PT

  White Matter Fingerprints: Tract-Specific DTI Predictors for Radiosurgical Thalamotomy in Parkinson's Tremor

  Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai